https://ph-ksp.com/historically-marginalized-and-minoritized-populations-with-pah-a-deeper-dive-into-a-complex-question-chest-july-14-2026/ 2026-07-30T04:59:22Z PULMONARY HYPERTENSION en Historically Marginalized And Minoritized Populations With Pulmonary Arterial Hypertension: A Deeper Dive Into a Complex Question, CHEST July 14, 2026 2026-07-30T04:58:13Z Blog https://ph-ksp.com/the-ethical-application-of-artificial-intelligence-in-digital-health-european-heart-journal-digital-health-volume-7-issue-6-july-2026/ 2026-07-30T04:32:40Z PULMONARY HYPERTENSION en The Ethical Application of Artificial Intelligence in Digital Health, European Heart Journal - Digital Health, Volume 7, Issue 6, July 2026 2026-07-30T04:29:38Z Blog https://ph-ksp.com/ralinepag-for-the-treatment-of-pulmonary-arterial-hypertension-advance-outcomes/ 2026-07-30T04:11:05Z PULMONARY HYPERTENSION en Ralinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): findings from the phase 3 study, The Lancet, July 26, 2026 2026-07-30T04:08:39Z Blog https://ph-ksp.com/u-s-food-and-drug-administration-fda-grants-orphan-drug-status-to-ikt-001-an-experimental-formulation-of-imatinib-to-treat-pulmonary-arterial-hypertension-july-23-2026/ 2026-07-29T04:18:17Z PULMONARY HYPERTENSION en U.S. Food and Drug Administration (FDA) grants orphan drug status to IKT-001, an experimental formulation of imatinib to treat pulmonary arterial hypertension, July 23, 2026 2026-07-29T04:18:15Z Blog